Compare $GOVX vs $KAPA | Chartloom

Compare

$GOVX vs $KAPA

GeoVax Labs Inc · Kairos Pharma Ltd

GOVX

GeoVax Labs Inc

KAPA

Kairos Pharma Ltd

Compare $GOVX vs $KAPA

Comparing GeoVax Labs Inc and Kairos Pharma Ltd

GOVXGeoVax Labs Inc

KAPAKairos Pharma Ltd

GOVXGeoVax Labs Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

-94.6%

52W performance

-98.1%

FCF yield

-950.7%

KAPAKairos Pharma Ltd

Market cap

$17M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-84.1%

52W performance

-91.2%

FCF yield

-22.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GOVX

KAPA

Detailed metrics comparison

GOVX

GeoVax Labs Inc

KAPA

Kairos Pharma Ltd

Market Cap

GOVX$2M

KAPA$17M

Enterprise Value

GOVX$-1M

KAPA$15M

Price

GOVX$0.28

KAPA$0.81

P/E Ratio

GOVXN/A

KAPAN/A

P/S Ratio

GOVX0.53x

KAPA0.00x

EV/Sales

GOVX0.01x

KAPA0.00x

EV/EBITDA

GOVX0.00x

KAPA0.00x

P/B Ratio

GOVX1.84x

KAPA1.26x

P/FCF Ratio

GOVXN/A

KAPAN/A

EV/FCF

GOVX0.05x

KAPA-3.71x

PEG Ratio

GOVXN/A

KAPAN/A

Forward P/E (NTM)

GOVXN/A

KAPAN/A

Forward P/S (NTM)

GOVXN/A

KAPAN/A

Revenue (TTM)

GOVX$0

KAPA$0

Revenue Growth (YoY)

GOVX-100.0%

KAPAN/A

Forward Rev Growth

GOVX0.0%

KAPA0.0%

Gross Margin (TTM)

GOVX0.0%

KAPA0.0%

Operating Margin (TTM)

GOVX0.0%

KAPA0.0%

EBITDA Margin (TTM)

GOVX0.0%

KAPA0.0%

Net Margin (TTM)

GOVX0.0%

KAPA0.0%

FCF Margin (TTM)

GOVXN/A

KAPAN/A

Net Income (TTM)

GOVX$-20M

KAPA$-6M

FCF (TTM)

GOVX$-20M

KAPA$-4M

EPS (TTM)

GOVX-$4.47

KAPA-$0.27

ROE (TTM)

GOVX-74366.0%

KAPA-9877.0%

ROA (TTM)

GOVX-39473.0%

KAPA-9361.0%

ROIC (TTM)

GOVX-74366.0%

KAPA-9877.0%

Cash

GOVX$3M

KAPA$3M

Debt

GOVX$0

KAPA$0

Net Cash/Debt

GOVX$3M

KAPA$3M

Current Ratio (TTM)

GOVX1.54x

KAPA11.98x

Quick Ratio (TTM)

GOVX1.16x

KAPA11.46x

Debt/Equity (TTM)

GOVX0.00x

KAPA0.00x

Debt/Assets (TTM)

GOVX0.0%

KAPA0.0%

Interest Coverage (TTM)

GOVXN/A

KAPAN/A

Net Debt/EBITDA (TTM)

GOVX0.00x

KAPA0.00x

Beta

GOVX3.89

KAPA3.30

52W Performance

GOVX-98.1%

KAPA-91.2%

YTD Performance

GOVX-94.6%

KAPA-84.1%

% from 52W High

GOVX-98.2%

KAPA-91.6%

% from 52W Low

GOVX3.9%

KAPA3.5%

Asset Turnover (TTM)

GOVX0.69x

KAPA0.00x

FCF Yield (TTM)

GOVX-950.7%

KAPA-22.9%

Earnings Yield (TTM)

GOVX-986.3%

KAPA-33.5%

Dividend Yield (TTM)

GOVXN/A

KAPAN/A

Rule of 40

GOVX-100.0

KAPA0.0

EV/GP/RG

GOVXN/A

KAPAN/A

Ticker research

View GOVX research View KAPA research

Metric	GOVX GeoVax Labs Inc	KAPA Kairos Pharma Ltd
Market & Valuation
Market Cap	$2M	$17M
Enterprise Value	$-1M	$15M
Price	$0.28	$0.81
P/E Ratio	N/A	N/A
P/S Ratio	0.53x	0.00x
EV/Sales	0.01x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.84x	1.26x
P/FCF Ratio	N/A	N/A
EV/FCF	0.05x	-3.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-20M	$-6M
FCF (TTM)	$-20M	$-4M
EPS (TTM)	-$4.47	-$0.27
ROE (TTM)	-74366.0%	-9877.0%
ROA (TTM)	-39473.0%	-9361.0%
ROIC (TTM)	-74366.0%	-9877.0%
Financial Health
Cash	$3M	$3M
Debt	$0	$0
Net Cash/Debt	$3M	$3M
Current Ratio (TTM)	1.54x	11.98x
Quick Ratio (TTM)	1.16x	11.46x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.89	3.30
52W Performance	-98.1%	-91.2%
YTD Performance	-94.6%	-84.1%
% from 52W High	-98.2%	-91.6%
% from 52W Low	3.9%	3.5%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	0.00x
FCF Yield (TTM)	-950.7%	-22.9%
Earnings Yield (TTM)	-986.3%	-33.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View GOVX research	View KAPA research

Valuation

P/S Ratio

KAPA

0.00x

GOVX

0.53x

EV/FCF

KAPA

-3.71x

GOVX

0.05x

Growth & revenue

Revenue Growth TTM

GOVX

-100.0%

Forward Revenue Growth

GOVX

0.0%

KAPA

0.0%

Profitability & performance

Gross Margin

GOVX

0.0%

KAPA

0.0%

ROE

KAPA

-9877.0%

GOVX

-74366.0%

FCF Yield %

KAPA

-22.9%

GOVX

-950.7%

52-Week Performance

KAPA

-91.2%

GOVX

-98.1%

Detailed metrics comparison

GOVX

GeoVax Labs Inc

KAPA

Kairos Pharma Ltd

Market Cap

GOVX$2M

KAPA$17M

Enterprise Value

GOVX$-1M

KAPA$15M

Price

GOVX$0.28

KAPA$0.81

P/E Ratio

GOVXN/A

KAPAN/A

P/S Ratio

GOVX0.53x

KAPA0.00x

EV/Sales

GOVX0.01x

KAPA0.00x

EV/EBITDA

GOVX0.00x

KAPA0.00x

P/B Ratio

GOVX1.84x

KAPA1.26x

P/FCF Ratio

GOVXN/A

KAPAN/A

EV/FCF

GOVX0.05x

KAPA-3.71x

PEG Ratio

GOVXN/A

KAPAN/A

Forward P/E (NTM)

GOVXN/A

KAPAN/A

Forward P/S (NTM)

GOVXN/A

KAPAN/A

Revenue (TTM)

GOVX$0

KAPA$0

Revenue Growth (YoY)

GOVX-100.0%

KAPAN/A

Forward Rev Growth

GOVX0.0%

KAPA0.0%

Gross Margin (TTM)

GOVX0.0%

KAPA0.0%

Operating Margin (TTM)

GOVX0.0%

KAPA0.0%

EBITDA Margin (TTM)

GOVX0.0%

KAPA0.0%

Net Margin (TTM)

GOVX0.0%

KAPA0.0%

FCF Margin (TTM)

GOVXN/A

KAPAN/A

Net Income (TTM)

GOVX$-20M

KAPA$-6M

FCF (TTM)

GOVX$-20M

KAPA$-4M

EPS (TTM)

GOVX-$4.47

KAPA-$0.27

ROE (TTM)

GOVX-74366.0%

KAPA-9877.0%

ROA (TTM)

GOVX-39473.0%

KAPA-9361.0%

ROIC (TTM)

GOVX-74366.0%

KAPA-9877.0%

Cash

GOVX$3M

KAPA$3M

Debt

GOVX$0

KAPA$0

Net Cash/Debt

GOVX$3M

KAPA$3M

Current Ratio (TTM)

GOVX1.54x

KAPA11.98x

Quick Ratio (TTM)

GOVX1.16x

KAPA11.46x

Debt/Equity (TTM)

GOVX0.00x

KAPA0.00x

Debt/Assets (TTM)

GOVX0.0%

KAPA0.0%

Interest Coverage (TTM)

GOVXN/A

KAPAN/A

Net Debt/EBITDA (TTM)

GOVX0.00x

KAPA0.00x

Beta

GOVX3.89

KAPA3.30

52W Performance

GOVX-98.1%

KAPA-91.2%

YTD Performance

GOVX-94.6%

KAPA-84.1%

% from 52W High

GOVX-98.2%

KAPA-91.6%

% from 52W Low

GOVX3.9%

KAPA3.5%

Asset Turnover (TTM)

GOVX0.69x

KAPA0.00x

FCF Yield (TTM)

GOVX-950.7%

KAPA-22.9%

Earnings Yield (TTM)

GOVX-986.3%

KAPA-33.5%

Dividend Yield (TTM)

GOVXN/A

KAPAN/A

Rule of 40

GOVX-100.0

KAPA0.0

EV/GP/RG

GOVXN/A

KAPAN/A

Ticker research

View GOVX research View KAPA research

Metric	GOVX GeoVax Labs Inc	KAPA Kairos Pharma Ltd
Market & Valuation
Market Cap	$2M	$17M
Enterprise Value	$-1M	$15M
Price	$0.28	$0.81
P/E Ratio	N/A	N/A
P/S Ratio	0.53x	0.00x
EV/Sales	0.01x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.84x	1.26x
P/FCF Ratio	N/A	N/A
EV/FCF	0.05x	-3.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-20M	$-6M
FCF (TTM)	$-20M	$-4M
EPS (TTM)	-$4.47	-$0.27
ROE (TTM)	-74366.0%	-9877.0%
ROA (TTM)	-39473.0%	-9361.0%
ROIC (TTM)	-74366.0%	-9877.0%
Financial Health
Cash	$3M	$3M
Debt	$0	$0
Net Cash/Debt	$3M	$3M
Current Ratio (TTM)	1.54x	11.98x
Quick Ratio (TTM)	1.16x	11.46x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.89	3.30
52W Performance	-98.1%	-91.2%
YTD Performance	-94.6%	-84.1%
% from 52W High	-98.2%	-91.6%
% from 52W Low	3.9%	3.5%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	0.00x
FCF Yield (TTM)	-950.7%	-22.9%
Earnings Yield (TTM)	-986.3%	-33.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View GOVX research	View KAPA research